Treatment

Grafalon 20 mg/ml concentrato per soluzione per infusione clinical trials

2 indexed studies · 0 currently recruiting

AuthorisedPhase II and Phase III (Integrated)
Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients: a Spanish Multicenter, Randomized, Controlled Parallel-group Trial: The TRAINING Study
This study, called 'The TRAINING Study', looks at whether treating early, minor issues (borderline lesions) in transplanted kidneys helps them work better long-term. Researchers compare a specific treatment to standard care in people who have had a kidney transplant and are at low risk of rejection.
For: To analyze whether the anti-rejection treatment of borderline lesions can modify the expression and klotho levels · as well as proinflammatory cytokines that regulate klotho expression at both years post-transplant. · Know in a controlled and randomized clinical trial
Spain
AuthorisedTherapeutic exploratory (Phase II)
Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell Transplantation (allo-SCT) in Acute Myeloid Leukemia (AML) patients (≥40 <65years)
This study is looking at a new way to prepare people with acute myeloid leukaemia (AML) for a stem cell transplant. It's testing a combination of medicines (Fludarabine and Treosulfan) to see if it's safe and effective for adults aged 40 to 65.
For: Acute Myeloid Leukemia (AML)
Italy